| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:00 UTC |
|---|
| HMDB ID | HMDB0015493 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Aminophenazone |
|---|
| Description | Aminophenazone is only found in individuals that have used or taken this drug. It is a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of cytochrome P-450 metabolic activity in liver function tests. [PubChem]Aminophenazone is metabolized very slowly by normal newborn babies. In older infants, a higher amount of exhaled 13-CO2 is observed. |
|---|
| Structure | CN(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1 InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3 |
|---|
| Synonyms | | Value | Source |
|---|
| (Dimethylamino)phenazone | ChEBI | | 1,5-Dimethyl-4-dimethylamino-2-phenyl-3-pyrazolone | ChEBI | | 1-Phenyl-2,3-dimethyl-4-(dimethylamino)-5-pyrazolone | ChEBI | | 1-Phenyl-2,3-dimethyl-4-dimethylaminopyrazol-5-one | ChEBI | | 2,3-Dimethyl-4-dimethylamino-1-phenyl-5-pyrazolone | ChEBI | | 3-Keto-1,5-dimethyl-4-dimethylamino-2-phenyl-2,3-dihydropyrazole | ChEBI | | 4-(Dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one | ChEBI | | 4-(Dimethylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one | ChEBI | | 4-(Dimethylamino)antipyrine | ChEBI | | 4-Dimethylamino-1-phenyl-2,3-dimethylpyrazolone | ChEBI | | 4-Dimethylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one | ChEBI | | 4-Dimethylamino-2,3-dimethyl-1-phenyl-5-pyrazolone | ChEBI | | 4-Dimethylaminoantipyrine | ChEBI | | 4-Dimethylaminophenazone | ChEBI | | Aminofenazona | ChEBI | | Aminofenazone | ChEBI | | Aminophenazon | ChEBI | | Aminophenazonum | ChEBI | | Aminopyrine | ChEBI | | Dimethylaminoantipyrine | ChEBI | | Dimethylaminoazophene | ChEBI | | Dimethylaminophenazon | ChEBI | | Dimethylaminophenazone | ChEBI | | Dimethylaminophenyldimethylpyrazolone | ChEBI | | Dipyrine | ChEBI | | Amidophen | HMDB | | Amidophenazon | HMDB | | Aminophenazone berlin-chemie brand | HMDB | | Berlin-chemie brand OF aminophenazone | HMDB | | Dimethyl-N-aminoantipyrine | HMDB | | Berlin chemie brand OF aminophenazone | HMDB | | Dimethyl N aminoantipyrine | HMDB | | Eufibron | HMDB | | Amidazophen | HMDB | | Amidopyrine | HMDB |
|
|---|
| Chemical Formula | C13H17N3O |
|---|
| Average Molecular Weight | 231.2936 |
|---|
| Monoisotopic Molecular Weight | 231.137162181 |
|---|
| IUPAC Name | 4-(dimethylamino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one |
|---|
| Traditional Name | aminophenazone |
|---|
| CAS Registry Number | 58-15-1 |
|---|
| SMILES | CN(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3 |
|---|
| InChI Key | RMMXTBMQSGEXHJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Azoles |
|---|
| Sub Class | Pyrazoles |
|---|
| Direct Parent | Phenylpyrazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpyrazole
- Tertiary aliphatic/aromatic amine
- Dialkylarylamine
- Monocyclic benzene moiety
- Pyrazolinone
- Benzenoid
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Tertiary amine
- Azacycle
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 134.5 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 22.5 g/L | Not Available | | LogP | 1.00 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.79 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9174 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.82 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 33.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1194.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 237.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 136.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 162.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 55.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 323.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 139.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 748.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 257.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 693.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 227.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 219.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 341.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 267.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 121.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Aminophenazone EI-B (Non-derivatized) | splash10-053s-9250000000-c3308b81b44067a47f7e | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Aminophenazone EI-B (Non-derivatized) | splash10-0a4i-9100000000-40e7051a3536ae680d1a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Aminophenazone EI-B (Non-derivatized) | splash10-053s-9250000000-c3308b81b44067a47f7e | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Aminophenazone EI-B (Non-derivatized) | splash10-0a4i-9100000000-40e7051a3536ae680d1a | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Aminophenazone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0159-4970000000-8cb60fc41366bf1c7f80 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Aminophenazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-03dr-1900000000-49de43a88698c1df262b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-001i-0190000000-d7bfbe39ac8d423c5cfd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-03e9-4940000000-243b2713c256a2ab8b6c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-03dj-9700000000-3ef4e69c38623bfd699f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-06r2-9300000000-762e3df6382a5e2052a3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-0592-9100000000-b9c175ecf48888c0267a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-0a4j-9100000000-9fa64e7904c1473d9d32 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-001i-0290000000-27bac0f1542859b73671 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-03e9-4940000000-a4c3f3e347d595ad803e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-03dj-9700000000-ac217c24c44682808465 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-06xt-9300000000-f8259f5a45014efc58ee | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-052b-9100000000-307762c9c387df2fcbf4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-0a4j-9100000000-3c5267564fda210cc134 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-ITFT , positive-QTOF | splash10-03dr-1900000000-ab951ea405c6154ef630 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-QQ , positive-QTOF | splash10-001i-0090000000-2527cae3cd95916624e4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-QQ , positive-QTOF | splash10-03di-3910000000-f7ee26001f3fbe463bae | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-QQ , positive-QTOF | splash10-01vk-9400000000-243fad64356c2d2c4864 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-QQ , positive-QTOF | splash10-0592-9100000000-bbc78ee3e540bd560a88 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminophenazone LC-ESI-QQ , positive-QTOF | splash10-0aba-9000000000-1c4e7d6f8c8bbdc08335 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminophenazone 10V, Positive-QTOF | splash10-001i-0090000000-0896fba0b89cb8cb6ff5 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminophenazone 20V, Positive-QTOF | splash10-001i-2390000000-eaa608d1cc64b37d59df | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminophenazone 40V, Positive-QTOF | splash10-001i-9100000000-db54dcd1f4d6da575bf1 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminophenazone 10V, Negative-QTOF | splash10-00di-3920000000-00258f4a6df2920817cc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminophenazone 20V, Negative-QTOF | splash10-0f8i-5790000000-dd0fbe214d13e5ebfde8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminophenazone 40V, Negative-QTOF | splash10-00l6-9300000000-18386f94d530fc45afc1 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|